Drug Trials Snapshots: SOFDRA

Drug Trials Snapshots: SOFDRA

Summary

SOFDRA is an anticholinergic antiperspirant approved for primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.

Description

SOFDRA is an anticholinergic antiperspirant approved for primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source